Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Ensoma, Inc.
Ensoma, Inc. is an in vivo Gene Therapy founded in 2019.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Organization
Company
CEO
Emile Nuwaysir
CIK Number
1,846,902
Legal Name
Ensoma, Inc.
Company Operating Status
Active
Country
United States
Crunchbase URL
crunchbase.com/organiz...n/ensoma
CTO
Daniel LeBlanc (settler)
Date Incorporated
2019
Email Address
katie@1abmedia.com
Founded Date
2019
Industry
Biomedical engineering
Biology
Genomics
Genome editing
Tissue engineering
Healthcare
Regenerative medicine
Engineering
Biotechnology
Drug discovery
•••
Investors
Alexandria Venture Investments
Symbiosis II
RIT Capital Partners
Viking Global Investors
5AM Ventures
Takeda Ventures
Cormorant Asset Management
F-Prime Capital Partners
Cormorant Capital
Latest Funding Round Date
February 2021
Latest Funding Type
Series A
Legal classification
Corporation
LinkedIn URL
@company/ensomabio
Location
Copenhagen
Boston
Number of Employees
78
Number of Employees (Ranges)
51 – 200
0
Pitchbook URL
pitchbook.com/profiles...460025-56
Place of Incorporation
Delaware
Technologies Used
CRISPR
Total Funding Amount (USD)
70,549,902
Twitter URL
@EnsomaBio
Official Website
ensoma.com
twelve.bio
Find more companies like Ensoma, Inc.
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE